Philips appoints Jie Xue as Chief Business Leader Precision Diagnosis, co-leader of the Diagnosis & Treatment segment, and Özlem Fidanci as Chief of International Region
Philips (NYSE: PHG) has announced two key executive appointments effective January 1, 2025. Jie Xue has been appointed as Chief Business Leader Precision Diagnosis and co-leader of the Diagnosis & Treatment segment, joining from GE Healthcare where she served as President and CEO of Global Magnetic Resonance Imaging. Özlem Fidanci has been named Chief of International Region, joining from Versuni after a previous 22-year career at Philips.
Both executives will join Philips' Executive Committee, reporting directly to CEO Roy Jakobs. Xue replaces Bert van Meurs, who was temporarily leading Precision Diagnosis and will continue to lead Philips' Image Guided Therapy business. Fidanci succeeds Edwin Paalvast, who is retiring after five years at Philips.
Philips (NYSE: PHG) ha annunciato due importanti nomine esecutive che entreranno in vigore il 1 gennaio 2025. Jie Xue è stata nominata Chief Business Leader Precision Diagnosis e co-leader del segmento Diagnosis & Treatment, proveniente da GE Healthcare, dove ha ricoperto il ruolo di Presidente e CEO della divisione Global Magnetic Resonance Imaging. Özlem Fidanci è stata nominata Chief of International Region, arrivando da Versuni dopo una carriera precedente di 22 anni in Philips.
Entrambi gli esecutivi entreranno a far parte del Comitato Esecutivo di Philips, riportando direttamente al CEO Roy Jakobs. Xue subentra a Bert van Meurs, che ha temporaneamente guidato Precision Diagnosis e continuerà a dirigere il business Image Guided Therapy di Philips. Fidanci succede a Edwin Paalvast, che va in pensione dopo cinque anni in Philips.
Philips (NYSE: PHG) ha anunciado dos importantes nombramientos ejecutivos que entrarán en vigor el 1 de enero de 2025. Jie Xue ha sido nombrada Directora Comercial de Diagnóstico de Precisión y co-líder del segmento de Diagnóstico y Tratamiento, uniéndose desde GE Healthcare donde fue Presidenta y CEO de Imágenes por Resonancia Magnética Global. Özlem Fidanci ha sido nombrada Jefa de la Región Internacional, proveniente de Versuni tras una anterior carrera de 22 años en Philips.
Ambos ejecutivos se unirán al Comité Ejecutivo de Philips, reportando directamente al CEO Roy Jakobs. Xue reemplaza a Bert van Meurs, quien lideró temporalmente el Diagnóstico de Precisión y continuará liderando el negocio de Terapia Guiada por Imágenes de Philips. Fidanci sucede a Edwin Paalvast, quien se jubila después de cinco años en Philips.
Philips (NYSE: PHG)는 2025년 1월 1일부터 시행되는 두 가지 주요 임원 인사를 발표했습니다. Jie Xue가 정밀 진단에 대한 최고 사업 리더와 진단 및 치료 세그먼트의 공동 리더로 임명되었으며, GE 헬스케어에서 글로벌 자기 공명 영상의 회장 겸 CEO로 재직하였습니다. Özlem Fidanci는 국제 지역의 책임자로 임명되었으며, Versuni에서 이전의 22년 경력을 쌓은 뒤 Philips에 합류했습니다.
이 두 임원은 Philips의 경영 위원회에 합류하여 CEO인 Roy Jakobs에게 직접 보고합니다. Xue는 Bert van Meurs를 대체하며, 그는 정밀 진단을 일시적으로 이끌었고 Philips의 영상 유도 치료 사업을 계속 이끌 예정입니다. Fidanci는 Philips에서 5년 동안 재직한 Edwin Paalvast의 뒤를 잇습니다.
Philips (NYSE: PHG) a annoncé deux nominations exécutives clés qui entreront en vigueur le 1er janvier 2025. Jie Xue a été nommée cheffe commerciale pour le diagnostic précis et co-leader du segment diagnostic et traitement, rejoignant l'entreprise après avoir été présidente et PDG de l'imagerie par résonance magnétique globale chez GE Healthcare. Özlem Fidanci a été désignée cheffe de la région internationale, venant de Versuni après une carrière de 22 ans chez Philips.
Les deux dirigeantes rejoindront le Comité Exécutif de Philips, reportant directement au PDG Roy Jakobs. Xue remplace Bert van Meurs, qui a dirigé temporairement le diagnostic précis et continuera à diriger le secteur de la thérapie guidée par l'image de Philips. Fidanci succède à Edwin Paalvast, qui prend sa retraite après cinq ans chez Philips.
Philips (NYSE: PHG) hat zwei wichtige Ernennungen auf leitender Ebene angekündigt, die am 1. Januar 2025 wirksam werden. Jie Xue wurde zur Chief Business Leader für präzise Diagnostik und Co-Leiterin des Segmentes Diagnostik & Behandlung ernannt und kommt von GE Healthcare, wo sie als Präsidentin und CEO der Global Magnetic Resonance Imaging tätig war. Özlem Fidanci wurde zur Leiterin der internationalen Region ernannt und kommt von Versuni, nachdem sie zuvor 22 Jahre bei Philips tätig war.
Beide Führungskräfte werden Teil des Executive Committees von Philips und berichten direkt an CEO Roy Jakobs. Xue ersetzt Bert van Meurs, der vorübergehend die präzise Diagnostik geleitet hat und weiterhin das Geschäft mit bildgebend geführter Therapie bei Philips leiten wird. Fidanci tritt die Nachfolge von Edwin Paalvast an, der nach fünf Jahren bei Philips in den Ruhestand geht.
- Strategic strengthening of executive leadership with experienced industry veterans
- Appointment of leader with 25+ years GE Healthcare experience to head Precision Diagnosis
- Addition of executive with proven track record in both mature and emerging markets
- None.
January 9, 2025
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the appointment of Jie Xue as Chief Business Leader Precision Diagnosis, and Özlem Fidanci as Chief of International Region, both effective January 1, 2025. Ms. Xue and Ms. Fidanci have joined Philips' Executive Committee and report directly to Roy Jakobs, CEO of Philips.
Ms. Xue joins Philips from GE Healthcare to lead the Precision Diagnosis business that was temporarily led by Bert van Meurs, who will continue to lead Philips’ Image Guided Therapy business. Ms. Xue and Mr. Van Meurs will be jointly responsible for the Diagnosis & Treatment segment.
Ms. Fidanci joins from Versuni and succeeds Edwin Paalvast, Chief of International Region, who has decided to retire as planned after five years at Philips, concluding an impressive career spanning more than 35 years.
Roy Jakobs, CEO Philips, said: “In Jie we have a strong proven global leader, with deep medtech expertise, and a focus on creating value through developing people and consistently delivering results. Özlem brings an extensive track record in delivering high growth in mature and emerging markets, working closely with customers and governments. She has strong experience in consumer and medtech domains and is known for building high-performing teams. Jie and Özlem strengthen our experienced and diverse leadership team and will support us in realizing our vision of better care for more people.”
“I want to thank Edwin for his leadership and many achievements during his five years at Philips and wish him all the very best for his retirement. I also want to express my gratitude to Bert for leading Precision Diagnosis alongside his role as Chief Business Leader Image Guided Therapy and look forward to his continued leadership and support as Executive Committee member of Philips.”
Ms. Xue (American, Chinese) worked for GE Healthcare for more than 25 years, most recently in the role of President and Chief Executive Officer, Global Magnetic Resonance (MR) Imaging. Based on her deep domain knowledge, she developed and executed imaging strategies, delivering consistent profitable growth. With her extensive global experience, particularly in the US, she has served in leadership roles including in Global X-ray, MR, Services and Business Development.
Ms. Fidanci (Turkish) had an extensive career at Philips, with deep expertise serving health systems' needs, including working directly with both private and public healthcare customers, as well as extensive consumer domain experience. During her 22 years at the company, she took on various roles including Health Systems Leader and Market Leader Middle East & Türkiye, before leaving in September 2021.
Additional information on Philips’ Executive Committee can be found here.
For further information, please contact:
Ben Zwirs
Philips External Relations
Tel.: +31 6 1521 3446
E-mail: ben.zwirs@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,300 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Attachments
FAQ
Who is the new Chief Business Leader of Precision Diagnosis at Philips (PHG)?
Who is replacing Edwin Paalvast as Chief of International Region at Philips (PHG)?
What experience does Jie Xue bring to Philips (PHG)?
What is Özlem Fidanci's background before joining Philips (PHG) as Chief of International Region?
